Adiponectin

  • Blockade of the RAS increases plasma adiponectin in subjects with metabolic syndrome and enhances differentiation and adiponectin expression of human preadipocytes.
    (Tian F, et al. Exp Clin Endocrinol Diabetes. 2009 Oct 23. [Epub ahead of print])
    View Abstract

Biomarkers

  • Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts.
    (Rizvi AA. Am J Med Sci. 2009 Oct;338(4):310-8. Review.)
    View Abstract
  • Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    (Sabio JM, et al. J Rheumatol. 2009 Oct;36(10):2204-11. Epub 2009 Sep 1.)
    View Abstract
  • Multiple biomarkers and their relative contributions to identifying metabolic syndrome.
    (Lee JG, et al. Clin Chim Acta. 2009 Oct;408(1-2):50-5. Epub 2009 Jul 19.)
    View Abstract

Cancer

  • The association of metabolic syndrome with triple-negative breast cancer.
    (Maiti B, et al. Breast Cancer Res Treat. 2009 Oct 23. [Epub ahead of print])
    View Abstract
  • Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer.
    (van Waas M, et al. Ann Oncol. 2009 Oct 22. [Epub ahead of print])
    View Abstract
  • Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.
    (Siegel AB, et al. Cancer. 2009 Oct 15. [Epub ahead of print])
    View Abstract

Cardiovascular Disease / Cardiac Function

  • Risk of smoking and metabolic syndrome for incidence of cardiovascular disease.
    (Higashiyama A, et al. Circ J. 2009 Oct 17. [Epub ahead of print])
    View Abstract
  • The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome.
    (Ruberg FL, et al. Obesity (Silver Spring). 2009 Oct 29. [Epub ahead of print])
    View Abstract
  • Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management.
    (Tziomalos K, et al. Nutr Metab Cardiovasc Dis. 2009 Oct 13. [Epub ahead of print])
    View Abstract
  • Serum heart type fatty acid binding protein levels in metabolic syndrome.
    (Akbal E, et al. Endocrine. 2009 Oct 6. [Epub ahead of print])
    View Abstract
  • Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
    (Zhang Y, et al. Endocrine. 2009 Oct;36(2):233-8. Epub 2009 Jul 18.)
    View Abstract
  • N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index.
    (Sezen Y, et al. Clin Biochem. 2009 Oct;42(15):1500-3. Epub 2009 Jul 16.)
    View Abstract

Cognitive Function

  • Metabolic syndrome over 10 years and cognitive functioning in late mid life: The Whitehall II study.
    (Akbaraly TN, et al. Diabetes Care. 2009 Oct 16. [Epub ahead of print])
    View Abstract
  • The effects of metabolic syndrome and apolipoprotein E4 on cognitive event-related potentials.
    (Lai CL, et al. Biol Psychol. 2009 Oct 29. [Epub ahead of print])
    View Abstract
  • Mental slowness and executive dysfunctions in patients with metabolic syndrome.
    (Segura B, et al. Neurosci Lett. 2009 Oct 2;462(1):49-53. Epub 2009 Jun 26.)
    View Abstract

Defining the Metabolic Syndrome

  • Variant metabolic risk factor profile leading to premature coronary disease: Time to define the syndrome of accelerated atherocoronary metabolic syndrome in Asian Indians.
    (Jayasinghe SR, et al. Singapore Med J. 2009 Oct;50(10):949-55.)
    View Abstract
  • The metabolic syndrome: definition, global impact, and pathophysiology.
    (Potenza MV, et al. Nutr Clin Pract. 2009 Oct-Nov;24(5):560-77.)
    View Abstract
  • Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
    (Sakurai T, et al. Gerontology. 2009 Oct 10. [Epub ahead of print])
    View Abstract
  • Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
    (Alberti KG, et al. Circulation. 2009 Oct 20;120(16):1640-5. Epub 2009 Oct 5.)
    View Abstract

Diabetes

  • Predicting new onset diabetes mellitus in older Taiwanese: Metabolic syndrome or impaired fasting glucose?
    (Chen LK, et al. J Atheroscler Thromb. 2009 Oct;16(5):627-32.)
    View Abstract
  • APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome.
    (Castro A, et al. Atherosclerosis. 2009 Oct 6. [Epub ahead of print])
    View Abstract
  • Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness.
    (Isogawa A, et al. Diabetes Res Clin Pract. 2009 Dec;86(3):213-8. Epub 2009 Oct 9.)
    View Abstract
  • Impact of metabolic syndrome on the progression of intima-media thickening in Japanese--a follow-up study.
    (Matoba Y, et al. Diabetes Res Clin Pract. 2009 Dec;86(3):e50-3. Epub 2009 Oct 8.)
    View Abstract
  • C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome.
    (Mavrakanas T, et al. Presse Med. 2009 Oct;38(10):1399-403. Epub 2009 May 5.)
    View Abstract

Diet, Nutrition, and Metabolism

  • Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.
    (Brown JM, et al. Arterioscler Thromb Vasc Biol. 2009 Oct 15. [Epub ahead of print])
    View Abstract
  • Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects.
    (Straznicky NE, et al. Diabetes. 2009 Oct 15. [Epub ahead of print])
    View Abstract
  • A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome.
    (van Dijk SJ, et al. Am J Clin Nutr. 2009 Oct 14. [Epub ahead of print])
    View Abstract
  • Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort.
    (Rumawas ME, et al. Am J Clin Nutr. 2009 Oct 14. [Epub ahead of print])
    View Abstract
  • Metabolic syndrome and changes in body fat from a low-fat diet and/or exercise randomized controlled trial.
    (Camhi SM, et al. Obesity (Silver Spring). 2009 Oct 1. [Epub ahead of print])
    View Abstract
  • Dietary patterns are associated with metabolic syndrome in adult Samoans.
    (DiBello JR, et al. J Nutr. 2009 Oct;139(10):1933-43. Epub 2009 Aug 26.)
    View Abstract
  • Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome.
    (Fessler MB, et al. Curr Opin Lipidol. 2009 Oct;20(5):379-85.)
    View Abstract
  • Adherence to the Mediterranean diet and risk of metabolic syndrome and its components.
    (Babio N, et al. Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):563-70. Epub 2009 Jan 26.)
    View Abstract
  • Asymmetric dimethylarginine association with antioxidants intake in healthy young adults: a role as an indicator of metabolic syndrome features.
    (Puchau B, et al. Metabolism. 2009 Oct;58(10):1483-8. Epub 2009 Jul 7.)
    View Abstract
  • Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: heads and tails of the same coin--resveratrol's role.
    (Cacciapuoti F. Metab Syndr Relat Disord. 2009 Oct;7(5):397-400.)
    View Abstract

Drug Therapy

  • New treatment with human atrial natriuretic peptide for postoperative myonephropathic metabolic syndrome.
    (Sezai A, et al. Ann Thorac Surg. 2009 Oct;88(4):1333-5.)
    View Abstract
  • Effects of different statin treatments on small dense low-density lipoprotein in patients with metabolic syndrome.
    (Bahadir MA, et al. J Atheroscler Thromb. 2009 Oct;16(5):684-90. Epub 2009 Sep 14.)
    View Abstract
  • Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen.
    (Lima LM, et al. Clinics (Sao Paulo). 2009 Oct;64(5):415-20.)
    View Abstract
  • The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.
    (Shelmadine B, et al. Anadolu Kardiyol Derg. 2009 Oct;9(5):385-9.)
    View Abstract
  • Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus.
    (Ferdinand KC, et al. J Clin Hypertens (Greenwich). 2009 Oct;11(10):585-93.)
    View Abstract

Epidemiology

  • Factors associated with metabolic syndrome in a sample of women in Puerto Rico.
    (Romaguera J, et al. Menopause. 2009 Oct 30. [Epub ahead of print])
    View Abstract
  • Salt excretion in normotensive individuals with metabolic syndrome: a population-based study.
    (Rodrigues SL, et al. Hypertens Res. 2009 Oct;32(10):906-10. Epub 2009 Aug 21.)
    View Abstract

Exercise

  • Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis.
    (Edwards JM, et al. Cardiovasc Res. 2009 Oct 4. [Epub ahead of print])
    View Abstract
  • Exercise training-induced changes in heart rate recovery in obese men with metabolic syndrome.
    (Kim MK, et al. Metab Syndr Relat Disord. 2009 Oct;7(5):469-76.)
    View Abstract
  • Cardiorespiratory fitness and the metabolic syndrome in firefighters.
    (Donovan R, et al. Occup Med (Lond). 2009 Oct;59(7):487-92. Epub 2009 Jul 3.)
    View Abstract
  • The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.
    (Barfield E, et al. J Pediatr Adolesc Gynecol. 2009 Oct;22(5):318-22. Epub 2009 Jul 2.)
    View Abstract

Genetics

  • Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults.
    (Mattei J, et al. J Nutr. 2009 Oct 14. [Epub ahead of print])
    View Abstract
  • CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids.
    (Garaulet M, et al. Am J Clin Nutr. 2009 Oct 21. [Epub ahead of print])
    View Abstract
  • Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo.
    (Shih PA, et al. J Clin Endocrinol Metab. 2009 Nov;94(11):4557-66. Epub 2009 Oct 9.)
    View Abstract
  • Association of the FTO gene with obesity and the metabolic syndrome is independent of the IRS-2 gene in the female population of Southern France.
    (Attaoua R, et al. Diabetes Metab. 2009 Oct 8. [Epub ahead of print])
    View Abstract
  • Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome.
    (Plagemann A, et al. J Physiol. 2009 Oct 15;587(Pt 20):4963-76. Epub 2009 Sep 1.)
    View Abstract
  • Variants in the insulin-degrading enzyme gene are associated with metabolic syndrome in Chinese elders.
    (Lu X, et al. Metabolism. 2009 Oct;58(10):1465-9. Epub 2009 Jul 9.)
    View Abstract
  • Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome.
    (Oguri M, et al. Atherosclerosis. 2009 Oct;206(2):486-93. Epub 2009 Mar 19.)
    View Abstract
  • Synergistic effects of ACE (I/D) and ApoE (HhaI) gene polymorphisms among the adult Asian Indians with and without metabolic syndrome.
    (Das M, et al. Diabetes Res Clin Pract. 2009 Dec;86(3):e58-61. Epub 2009 Oct 2.)
    View Abstract
  • Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study.
    (Fontaine-Bisson B, et al. J Mol Med. 2009 Oct 16. [Epub ahead of print])
    View Abstract
  • Heritabilities of the metabolic syndrome phenotypes and related factors in Korean twins.
    (Sung J, et al. J Clin Endocrinol Metab. 2009 Oct 16. [Epub ahead of print])
    View Abstract
  • Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome.
    (Phillips CM, et al. Am J Clin Nutr. 2009 Oct 14. [Epub ahead of print])
    View Abstract

Hypertension

  • Diuretic-induced potassium depletion and glucose intolerance are not related to hyperactivity of the renin-angiotensin-aldosterone system in hypertensive patients with the metabolic syndrome.
    (Barbieri DE, et al. J Clin Hypertens (Greenwich). 2009 Oct;11(10):549-54.)
    View Abstract

Innovative Techniques / Modeling

  • Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview.
    (Varga O, et al. Obes Rev. 2009 Oct 21. [Epub ahead of print])
    View Abstract
  • Adaptation and failure of pancreatic {beta} cells in murine models with different degrees of metabolic syndrome.
    (Medina-Gomez G, et al. Dis Model Mech. 2009 Nov-Dec;2(11-12):582-92. Epub 2009 Oct 19.)
    View Abstract
  • Vibration disrupts vascular function in a model of metabolic syndrome.
    (Krajnak K, et al. Ind Health. 2009 Oct;47(5):533-42.)
    View Abstract
  • Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome.
    (Marchesi C, et al. Hypertension. 2009 Dec;54(6):1384-1392. Epub 2009 Oct 12.)
    View Abstract
  • Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models.
    (Lin CC, et al. J Clin Psychiatry. 2009 Oct 6. [Epub ahead of print])
    View Abstract
  • Effect of gonadectomy on the metabolism of arachidonic acid in isolated kidney of a rat model of metabolic syndrome.
    (Pérez-Torres I, et al. Metabolism. 2009 Oct 2. [Epub ahead of print])
    View Abstract
  • Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity.
    (Esteghamati A, et al. Metab Syndr Relat Disord. 2009 Oct;7(5):447-52.)
    View Abstract
  • Tlr2 is critical for diet-induced metabolic syndrome in a murine model.
    (Himes RW, et al. FASEB J. 2009 Oct 19. [Epub ahead of print])
    View Abstract

Metabolic Syndrome in Children & Adolescents

  • Isolation and characterization of omental adipose progenitor cells in children: A potential tool to unravel the pathogenesis of metabolic syndrome.
    (Maiorana A, et al. Horm Res. 2009 Oct 21;72(6):348-358. [Epub ahead of print])
    View Abstract
  • Metabolic syndrome in children and adolescents - criteria for diagnosis.
    (Mancini MC. Diabetol Metab Syndr. 2009 Oct 19;1(1):20.)
    View Abstract
  • The stability of metabolic syndrome in children and adolescents.
    (Gustafson JK, et al. J Clin Endocrinol Metab. 2009 Oct 16. [Epub ahead of print])
    View Abstract
  • Persistence of the metabolic syndrome over 3 annual visits in overweight Hispanic children: association with progressive risk for type 2 diabetes.
    (Ventura EE, et al. J Pediatr. 2009 Oct;155(4):535-41. Epub 2009 Jun 24.)
    View Abstract
  • Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children.
    (Toledo-Corral CM, et al. Atherosclerosis. 2009 Oct;206(2):594-8. Epub 2009 Mar 25.)
    View Abstract
  • Prevalence of metabolic syndrome in US-born Latin and Caribbean youth.
    (Messiah SE, et al. J Immigr Minor Health. 2009 Oct;11(5):366-71. Epub 2009 Jan 6.)
    View Abstract
  • Predicting adult metabolic syndrome from childhood body mass index: follow-up of the New Delhi birth cohort.
    (Sachdev HP, et al. Arch Dis Child. 2009 Oct;94(10):768-74. Epub 2008 Nov 17.)
    View Abstract
  • Carotid intima-media thickness, dietary intake, and cardiovascular phenotypes in adolescents: relation to metabolic syndrome.
    (Croymans DM, et al. Metabolism. 2009 Oct 19. [Epub ahead of print])
    View Abstract
  • Anthropometric indices as predictors of the metabolic syndrome and its components in adolescents.
    (Jung C, et al. Pediatr Int. 2009 Oct 6. [Epub ahead of print])
    View Abstract
  • Prevalence and trends of metabolic syndrome among Korean adolescents: from the Korean NHANES survey, 1998-2005.
    (Park MJ, et al. J Pediatr. 2009 Oct;155(4):529-34. Epub 2009 Jun 24.)
    View Abstract
  • Fetal origins of insulin resistance and the metabolic syndrome: A key role for adipose tissue?
    (Meas T. Diabetes Metab. 2009 Oct 6. [Epub ahead of print])
    View Abstract

Metabolic Syndrome in Men

  • Indirect lifestyle intervention through wives improves metabolic syndrome components in men.
    (Matsuo T, et al. Int J Obes (Lond). 2009 Oct 27. [Epub ahead of print])
    View Abstract
  • Testosterone deficiency, insulin resistance and the metabolic syndrome.
    (Zitzmann M. Nat Rev Endocrinol. 2009 Dec;5(12):673-681. Epub 2009 Oct 27.)
    View Abstract

Metabolic Syndrome in Women

  • Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment.
    (Garruti G, et al. Reprod Biomed Online. 2009 Oct;19(4):552-63.)
    View Abstract
  • Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease.
    (Patel SM, et al. J Clin Endocrinol Metab. 2009 Oct 21. [Epub ahead of print])
    View Abstract
  • High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.
    (Coviello AD, et al. J Clin Endocrinol Metab. 2009 Nov;94(11):4361-6. Epub 2009 Oct 16.)
    View Abstract
  • Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high-density lipoprotein cholesterol serum level.
    (Dewailly D, et al. BJOG. 2009 Oct 13. [Epub ahead of print])
    View Abstract
  • Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny.
    (de Moura EG, et al. J Physiol. 2009 Oct 15;587(Pt 20):4919-29. Epub 2009 Sep 7.)
    View Abstract

Obesity

  • Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome.
    (Balci A, et al. Dermatology. 2009 Oct 29. [Epub ahead of print])
    View Abstract
  • Metabolic syndrome and insulin resistance in subjects with morbid obesity.
    (Soverini V, et al. Obes Surg. 2009 Oct 20. [Epub ahead of print])
    View Abstract
  • Joint association of obesity and metabolic syndrome with incident mobility limitation in older men and women--Results from the Health, Aging, and Body Composition Study.
    (Stenholm S, et al. J Gerontol A Biol Sci Med Sci. 2009 Oct 12. [Epub ahead of print])
    View Abstract
  • Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese.
    (Wang F, et al. Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):542-7. Epub 2009 Feb 1.)
    View Abstract
  • Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
    (Ng TW, et al. Clin Sci (Lond). 2009 Oct 2;118(1):79-85.)
    View Abstract
  • Waist-to-height ratio is a highly sensitive index for the metabolic syndrome in a Mediterranean population.
    (Mombelli G, et al. Metab Syndr Relat Disord. 2009 Oct;7(5):477-84.)
    View Abstract

Psychological Disorders

  • Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study.
    (Almeida OP, et al. Am J Geriatr Psychiatry. 2009 Oct;17(10):889-98.)
    View Abstract
  • Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan.
    (Huang MC, et al. Acta Psychiatr Scand. 2009 Oct;120(4):274-80. Epub 2009 May 7.)
    View Abstract

Risk Factors

  • Stressful life events and the metabolic syndrome: The PPP-Botnia Study.
    (Pyykkönen AJ, et al. Diabetes Care. 2009 Oct 30. [Epub ahead of print])
    View Abstract
  • Adipocytokines and the metabolic syndrome among older persons with and without obesity - the InCHIANTI Study.
    (Stenholm S, et al. Clin Endocrinol (Oxf). 2009 Oct 31. [Epub ahead of print])
    View Abstract
  • Atypical work hours and metabolic syndrome among police officers.
    (Violanti JM, et al. Arch Environ Occup Health. 2009 Fall;64(3):194-201.)
    View Abstract
  • Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations.
    (Yun JE, et al. Metabolism. 2009 Oct 19. [Epub ahead of print])
    View Abstract
  • Associations between lactase persistence and the metabolic syndrome in a cross-sectional study in the Canary Islands.
    (Almon R, et al. Eur J Nutr. 2009 Oct 22. [Epub ahead of print])
    View Abstract
  • 11{beta}-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation.
    (Cooper MS, et al. J Clin Endocrinol Metab. 2009 Oct 16. [Epub ahead of print])
    View Abstract
  • Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men.
    (Oda E, et al. Intern Med. 2009;48(20):1785-91. Epub 2009 Oct 15.)
    View Abstract
  • Elevated resting heart rate is associated with the metabolic syndrome.
    (Rogowski O, et al. Cardiovasc Diabetol. 2009 Oct 14;8:55.)
    View Abstract
  • Justice at work and metabolic syndrome: the Whitehall II Study.
    (Gimeno D, et al. Occup Environ Med. 2009 Oct 9. [Epub ahead of print])
    View Abstract
  • Analysis of the association between metabolic syndrome and disease in a workplace population over time.
    (Schultz AB, et al. Value Health. 2009 Oct 8. [Epub ahead of print])
    View Abstract
  • Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors.
    (Chang YC, et al. Eye (Lond). 2009 Oct 9. [Epub ahead of print])
    View Abstract
  • Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome.
    (Buscemi S, et al. Diabetes Res Clin Pract. 2009 Dec;86(3):177-85. Epub 2009 Oct 7.)
    View Abstract
  • Life course socioeconomic conditions and metabolic syndrome in adults: The Atherosclerosis Risk in Communities (ARIC) Study.
    (Chichlowska KL, et al. Ann Epidemiol. 2009 Oct 3. [Epub ahead of print])
    View Abstract
  • Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1.
    (Rakocevic Stojanovic V, et al. Acta Neurol Scand. 2009 Oct 5. [Epub ahead of print])
    View Abstract
  • Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 years.
    (Wang CC, et al. BJU Int. 2009 Oct 5. [Epub ahead of print])
    View Abstract
  • Metabolic syndrome: Aggression control mechanisms gone out of control.
    (Belsare PV, et al. Med Hypotheses. 2009 Oct 1. [Epub ahead of print])
    View Abstract
  • Relationship between metabolic syndrome and periodontal disease in Japanese adults.
    (Kushiyama M, et al. J Periodontol. 2009 Oct;80(10):1610-5.)
    View Abstract
  • High attendance at a lifestyle intervention program is important to reduce risks related to metabolic syndrome in middle-aged Japanese.
    (Fujii H, et al. Tohoku J Exp Med. 2009 Oct;219(2):155-64.)
    View Abstract
  • Metabolic syndrome in Argentinean patients with systemic lupus erythematosus.
    (Bellomio V, et al. Lupus. 2009 Oct;18(11):1019-25.)
    View Abstract
  • Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    (Gündogan K, et al. Metab Syndr Relat Disord. 2009 Oct;7(5):427-34.)
    View Abstract
  • The prevalence of carotid artery calcifications detected on panoramic radiographs in patients with metabolic syndrome.
    (Pornprasertsuk-Damrongsri S, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Oct;108(4):e57-62. Epub 2009 Aug 28.)
    View Abstract
  • Metabolic syndrome in early pregnancy and risk of preterm birth.
    (Chatzi L, et al. Am J Epidemiol. 2009 Oct 1;170(7):829-36. Epub 2009 Aug 27.)
    View Abstract
  • Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome.
    (Beltowski J, et al. Life Sci. 2009 Oct 7;85(15-16):557-67. Epub 2009 Aug 15.)
    View Abstract
  • Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome.
    (Setola E, et al. Diabetes Metab Res Rev. 2009 Oct;25(7):639-46.)
    View Abstract
  • Metabolic syndrome and the incidence of symptomatic deep vein thrombosis following total knee arthroplasty.
    (Gandhi R, et al. J Rheumatol. 2009 Oct;36(10):2298-301. Epub 2009 Aug 14.)
    View Abstract
  • Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area.
    (Ayturk S, et al. Eur J Endocrinol. 2009 Oct;161(4):599-605. Epub 2009 Jul 24.)
    View Abstract
  • Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.
    (Mattson MP. Exp Gerontol. 2009 Oct;44(10):625-33. Epub 2009 Jul 19.)
    View Abstract
  • Prevalence of metabolic syndrome and its relationship with leisure time physical activity among Peruvian adults.
    (Gelaye B, et al. Eur J Clin Invest. 2009 Oct;39(10):891-8. Epub 2009 Jun 26.)
    View Abstract
  • The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity.
    (Watz H, et al. Chest. 2009 Oct;136(4):1039-46. Epub 2009 Jun 19.)
    View Abstract
  • Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    (Grassi G, et al. Metabolism. 2009 Oct;58(10):1446-51. Epub 2009 Jun 18.)
    View Abstract
  • Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
    (Park JT, et al. Metabolism. 2009 Oct;58(10):1379-85. Epub 2009 Jun 18.)
    View Abstract
  • Relationship between two indicators of coronary risk estimated by the Framingham Risk Score and the number of metabolic syndrome components in Japanese male manufacturing workers.
    (Kawada T, et al. Metab Syndr Relat Disord. 2009 Oct;7(5):435-40.)
    View Abstract
  • Metabolic syndrome in a workplace: prevalence, co-morbidities, and economic impact.
    (Schultz AB, et al. Metab Syndr Relat Disord. 2009 Oct;7(5):459-68.)
    View Abstract
  • Relationship between peripheral arterial disease and metabolic syndrome.
    (Maksimovic M, et al. Angiology. 2009 Oct-Nov;60(5):546-53. Epub 2009 Jan 14.)
    View Abstract
IN THIS ISSUE:
NOVEMBER 2009
> In the News
> 2009 Ongoing Trials
> Recent Literature

Framingham Risk Assessment Tool
Estimates 10-year risk of developing hard CHD
> View Tool

Procam Risk Calculator
Estimates your risk of a heart attack (myocardial infarction) within the next 10 years based upon data of the PROCAM Study
> View Calculator


SCORE
(European High Risk Chart)

Estimates 10 year risk of fatal CVD in high risk regions of Europe by gender, age, systolic blood pressure, total cholesterol and smoking status.
> View Chart

UKPDS Risk Engine
The UKPDS Risk Engine is a type 2 diabetes specific risk calculator based on 53,000 patients years of data from the UK Prospective Diabetes Study, which also provides an approximate 'margin of error' for each estimate.
> View Risk Engine

Coordinated by Dr. Scott Grundy, Past-President of the IAS